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[who] were misclassified with respect to the
presence or absence of PPM.’’ Misclassifi-
cation is definitively more frequent when
the classification is based on fixed data,
either from in vitro study or previously pub-
lished studies, and not when the classifica-
tion is based on real in vivo data that
reflect the hemodynamic condition of a spe-
cific patient. The question of why some pa-
tients with the same prosthesis size had such
different postoperative EOAs is surely mat-
ter for further discussion and evaluation, but
postoperative in vivo EOA must anyway be
considered the criterion standard for PPM
identification and cannot be considered
simply misleading just because different
patients have different EOAs.
The final two comments of Pibarot and
coauthors are all related to the clinical effect
of PPM. With respect to the effect of PPM
on pulmonary arterial pressure, Pibarot and
coauthors simply underlined what we had
already stated in our Discussion section.
Furthermore, among three recent studies
quoted by Pibarot and coauthors, the one
from Li and colleagues6 was also a key ref-
erence in our study, and the two from Magne
and coauthors7 and Lam and coworkers8
were published well after we sent our article
for consideration for publication in the
Journal (February 2007, as clearly reported
on the first page1).
With respect to clinical impact of PPM in
terms of operative and late mortalities, we
also clearly stated in the Discussion section
that our study could not be elucidative be-
cause only 8 patients had PPM. Clinical rel-
evance of PPM has to be better elucidated
and surely represents an important matter.
We would like to stress, however, that
once more the evidence must come from
a complete evaluation and analysis of differ-
ent experiences published in the literature.
Recent experiences quoted by Pibarot and
coauthors7,8 clearly identify PPM as risk
factor for poor outcome. Previous experi-
ence from Lorusso and associates9 and
Ruel and coworkers,10 however, did not
confirm different outcome in patients re-
ceiving small prostheses. Because Lam
and coworkers’ definition of patients with
PPM was not based on postoperative in
vivo data,8 patients classified as having
PPM should mainly be patients receiving
small prostheses. These data are therefore
in contrast and deserve further evaluation
and further studies. In conclusion, in our
opinion only a multicenter, prospective
study that is based on in vivo postoperative
evaluation of PPM could reach a better level
of evidence regarding the exact definition of
PPM at the mitral level, the real incidence of
postoperative mitral PPM, and its clinical
impact. Our study was not meant to contra-
dict results from other researchers but sim-
ply to warn about the real potential for
misclassification of patients has having
PPM solely on the basis of fixed data rather
than dynamic data specific to that patient.
For the patient receiving a mitral prosthesis,
specific postoperative in vivo evaluation
should be mandatory to evaluate the real
incidence of mitral PPM.
Finally, we would respectfully underline
that the appropriate scientific controversy
should call for a different attitude and ap-
proach to other investigators simply driven
by the same enthusiasm for proven data
about a scientific aspect whose explanation,
unless proven, is usually not in the hands of
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To the Editor:
I read with great interest the recent article by
Dr Bakhtiary and colleagues1 detailing the
protective effect of high thoracic epidural
anesthesia against atrial fibrillation after
off-pump coronary bypass grafting. The
following clinical questions arise as a result
of this fascinating study:
1. Why was the placement of the
thoracic epidural catheters the day
before the operation?
2. Were there any thoracic epidural
placements complicated by signifi-
cant puncture-site bleeding? What
was the protocol for managing this
uncommon but important event?
Was another epidural space selected?
3. How was the epidural catheter tested
to ensure effective bilateral thoracic
anesthesia?
4. What was the management of postop-
erative b-blockade? Was b-blocker
withdrawal a possible confounder in
this study?
5. Is there any explanation for the
observation that women were more
likely to experience nausea and
vomiting in the intervention group?
6. What was the power calculation for
this study based on the existing liter-
ature? What is the probability of
a type I error, a type II error, or both?
like to point out the following issues in
response to his considerations.
The placement of the thoracic epidural
anesthesia (TEA) catheter at the day before
surgical intervention was recommended
based on study protocol to control any acute
catheter-related complications. Fortunately,
we did not have any neurological or respira-
tory complications in the TEA group during
our study.1 In case of any important compli-
cation, the patient would be excluded from
the study. In case of any bleeding complica-
tion, we would not recommend to reselect
another epidural space.2
Sensory block levels were determined
bilaterally by using loss of warm/cold sensa-
tion, as well as pinprick discrimination. The
levels of motor block were estimated in the
outplaced left arm by using an epidural an-
esthesia-scoring scale for arm movements.
Both sensory and motor block were checked
in 5-minute intervals until the desired anes-
thetic level was established.
The study protocol did not contain
any medication prophylaxis, such as a
b-blocker, against atrial fibrillation (AF).
Thirty-two patients in the general anesthesia
group and 35 patients in the general anesthe-
sia plus TEA group had a medication with
a b-blocker. It is well known that female
sex is one of the most predictive risk factors
for postoperative nausea and vomiting, and
the results of our study confirm the value
of this specific risk factor.3 The power cal-
culation for this study was 0.90, with an er-
ror probability of 0.50. We share the opinion
with Dr Augoustides that, based on recent
literature, the use of aprotinin in some
schema, such as the Hammersmith strict
perioperative management of hyperglyce-
mias, might have some protective effect on
prophylaxis of AF in patients undergoing
coronary bypass surgery.
There was a standard approach to man-
age perioperative hyperglycemias by using
insulin therapy to achieve blood glucose
values of less than 120 mg/dL. The study
protocol did not contain any medication
prophylaxis of magnesium against AF.
Farhad Bakhtiary, MDa
Hanns Ackermann, MD, PhDb
Dirk Meininger, MD, PhDc
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Effect of eliminating daily





We read with great interest the recent article
by Mets and colleagues1 describing the re-
sults of a study comparing the effects of
a routine versus on-demand chest x-ray
approach in postoperative cardiothoracic
surgery patients. The authors conclude that
the on-demand approach led to a reduction
in the number of chest radiographs per-
formed without changing x-ray practice on
their post—intensive care unit.
The practice of routine daily chest radio-
graphs has been frequently questioned in the
past.2 The authors themselves have docu-
mented a low number of unexpected find-
ings in routine chest radiographs and a low
impact of these finding on further therapy.3,4
As mentioned in the article, the authors have
therefore abandoned daily routine chest
radiographs for all patients in the intensive
care unit. All the more surprising is the
fact that this study was performed in a pro-
spective comparative fashion and that the
ethics committee deemed it unnecessary to
Letters to the Editor7. Is aprotinin exposure a consider-
ation, given its trend to protect
against atrial fibrillation after coro-
nary surgery?2
8. Is hyperglycemia a possible con-
founder, given its association with
higher rates of atrial fibrillation after
cardiac surgery?3 Was there a stan-
dardized approach to perioperative
glucose management? Insulin ther-
apy has been shown to be protective
against postoperative atrial fibrilla-
tion.4
9. Was perioperative magnesium ther-
apy standardized, given its link
with the incidence of atrial fibrilla-
tion after cardiac surgery?5
I congratulate the authors again on
a most excellent study. I look forward to
their feedback about these considerations.
John G. T. Augoustides, MD, FASE
Department of Anesthesiology and Critical Care
Hospital of the University of Pennsylvania
Philadelphia, Pa
Supported by the Department of Anesthesiology
and Critical Care, Hospital of the University of
Pennsylvania, Philadelphia, Pa.
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tides regarding our recent article1 and would
Selami Dogan, MD, PhDa




The quoted recommendations by the
American College of Radiology as a scien-
tific basis for daily routine chest radiographs
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